BAHAHAHAA.. good one. We're at that place where random

New Post Public Reply Private Reply Replies (0) Message Board
joey68 fourthjohn #1859
248
BAHAHAHAA.. good one. We're at that place where random people are going to start popping up.

im not going to delete his post so others can see how dumb it sounds haha and i screenprinted it so i can post it once we hit that high

Iconic Brands, Inc. (ICNB) Stock Research Links

ICNB Board Company Profile Buy Rating Time & Sales News Filings Financials
View My Board Here:
http://investorshangout.com/Joeys-Investment-Board-91611/


Invite Only

There is a VERY HIGH degree of RISK involved in trading and investing. Only invest what you can afford to lose.

Disclaimer:
As used herein, the terms "You" and "Your" shall mean you, individually, the reader, and each other party on whose behalf you may use the contained information at any time.
All references to "My", "I", and “The writer of the above post” shall refer to the creator of the username Joey68.

Do NOT invest unless you are prepared to sustain a total loss of the money you have invested plus any commission or other transaction charges.

There is a very high degree of risk involved in trading and investing. Past results are not indicative of future returns. I assume no responsibility for your trading and investment results. You should NOT rely on the information in the above post to make any decision or take any action.

ALL OF MY STATEMENTS, including but not limited to, POSTS, MESSAGES, PRIVATE MESSAGES, and RESPONSES are OPINION and NOT fact and are for entertainment purposes only. Do your own research and make your own decisions based on your own conclusions.
ALL OF MY STATEMENTS, including but not limited to, POSTS, MESSAGES, PRIVATE MESSAGES, and RESPONSES are NOT advice, and are NOT designed to substitute the expertise and judgment of a professional. It is your responsibility to seek investment advice during all stages of your investments. It is your responsibility to evaluate the accuracy, completeness and usefulness of the information in the above post.
I am NOT a professional.
I do NOT work for you.
My posts are NOT investment advice. I am not paid to post.
There is no correlation between the number of posts I write per day and your assumed success of a company.
It is NOT my responsibility to inform you of my own personal investment decisions.
It is NOT my responsibility to inform you when it is time for you to buy, hold, and/or sell a position.
I have no control over, and am not responsible for the actions of others who copy, store, edit, change, prepare any derivative work of or alter in any way any of the content provided in my posts.
Errors and Omissions expected. The writer of the above post accepts no liability or responsibility for any errors or omissions contained in the above post or contained within this Disclaimer.
The writer of the above post shall NOT accept any liability for the accuracy or completeness of the information contained in the above post, for any reliance placed by any person on the information contained in the above post, or for any damage or loss, however caused, in connection with the use or reliance on any information contained in the above post.
The above post may contain links to websites owned and operated by third parties. These links are provided for informational purposes only and are NOT endorsed by the writer of the above post. The writer of the above post has no control over the contents of any linked website and bears no responsibility for the accuracy, legality, or content of the external site or for that of subsequent links.
YOU ACCESS ALL LINKS ENTIRELY AT YOUR OWN RISK.
The writer of the above post makes no warranties or representations, express or implied about such linked websites, the third parties they are owned and operated by, or the information contained on these websites.
The writer of the above post accepts no liability for any damage or loss, however caused, in connection with the use of or reliance on any information, material, products, or services contained on or accessed through any such linked websites.

There is a VERY HIGH degree of RISK involved in trading and investing. Only invest what you can afford to lose.
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Chianti Classico Showcases 2027 Vintages in Florence

Updated Category News Views 0

A Grand Reunion of the Black Rooster You're not just sipping wine at a garden party—you're diving into a historic event. Come March 1-2, 2027, Florence will again host the much-anticipated Chianti Classico Collection, uniting over 200 eager producers under the iconic vaults of Stazione Leopolda. This isn't just another stop on the wine circuit; it's a pilgrimage to the...

Continue Reading
Zenni and Chase Stokes Foster Student Wellbeing in NYC

Updated Category News Views 0

Picture this: near 300 high schoolers milling around, glancing through shiny new glasses from the Zenni x Chase Stokes collection. In the heart of New York City, these kids are getting a double-dose of care that's all too rare—free vision screenings paired with mental health support. It's the kind of collaboration that shows you what's possible when a company, an actor,...

Continue Reading
Korea Tourism’s Quiz Offers Free Trip Sweepstakes

Updated Category News Views 1

A Shot at Adventure Without Opening Your Wallet Let me tell you, Korea's got a way of sweeping folks off their feet with a little something for everyone—from a foodie’s paradise to history buff heaven. The Korea Tourism Organization's (KTO) New York Office is lighting up the stage with a slick offer: enter a quiz on their website and you might just be jetting off to...

Continue Reading
Helio Genomics Shakes Up Liver Cancer Detection Strategy

Updated Category News Views 2

Rethinking Liver Cancer Detection with HelioLiver Sometimes you stumble upon a tech piece that might genuinely shake up the game. Helio Genomics just poured some serious intel at the San Antonio Liver Cancer Symposium, showcasing how their HelioLiver Dx might outgun traditional scans in sniffing out hepatocellular carcinoma (HCC). They threw down four studies revealing...

Continue Reading
Armor Health Strengthens Corrections Care with New Leader

Updated Category News Views 1

Fresh Blood in Correctional Healthcare Talk about stepping up where it counts! Armor Health is shaking things up, bringing in Jill Bromley as their new Regional Behavioral Health Director. The name might not ring any bells for the average Joe, but in the world of correctional healthcare, it’s like they've just upgraded from a sedan to a sports car. Armor’s game here...

Continue Reading
Poker Fans Flock to Venom PKOs and WSOP Paradise

Updated Category News Views 2

October's High Stakes Poker Action The poker buzz right now is centered around Americas Cardroom. With $5.5 million in guarantees across two major tournaments – the No-Limit Hold'em and Pot-Limit Omaha – players are reaching for their cash, hoping to lock in big wins. Day 1B kicks off today, offering a dynamic mix of players vying for their shot at glory while taking...

Continue Reading
Strategic Move: Chimney Collective Teams with Four Winds

Updated Category News Views 4

A Partnership Fueled by Legacy and Growth In the world of brick, mortar, and flue, a big play just unfolded. Chimney Collective, flexing its investment muscle, has hitched its wagon to Four Winds Chimney, a company that's carved out quite a niche in New York's chimney scene. We're not talking about a corporate takeover here; this is about putting money where growth and...

Continue Reading
Navigating Career Growth Beyond Job Titles at Webinar

Updated Category News Views 0

Hasn't it ever struck you that job titles often fence people in like some unwanted corral, keeping potential tightly leashed? Well, here's something that might shake up your thoughts a tad. University of Phoenix is teeing up a webinar titled "Beyond The Job Title: Finding Purpose and Recognizing the Value You Bring." Scheduled for October 15, 2026, this is all about...

Continue Reading
TKO's Bold $2B All-Cash Move for SVC's Hotels

Updated Category News Views 0

TKO's Big, Bold Bid: What Does it Mean? In the crazy world of high-stakes hospitality investments, there are moments that turn heads. TKO's $2 billion all-cash offer to snag Service Properties Trust's prized hotel portfolio is exactly one of those shake-ups. Let's not sugarcoat it; this is a bold move to the big leagues, and it's not without its quirks. A Cash-Infused...

Continue Reading
BETR Faces Securities Fraud Actions Post-Misleading Statements

Updated Category News Views 1

Unpacking the Legal Drama Around BETR The tale of Better Home & Finance Holding Company (BETR) is like a roadside crash you can't help but stare at. We're talking big, ugly losses and a chance for investors who got roughed up to throw some punches back with a securities fraud class action. The legal honchos at Howard G. Smith's law office are rallying the troops. If...

Continue Reading

Top 5 Most Recently Viewed Articles

Welltower's Remarkable Growth: $100 Investment Today Worth $1571

Updated Category News Views 214

Welltower's Growth Over 15 Years Welltower (NYSE: WELL), a leader in the real estate investment trust (REIT) sector, has shown impressive growth over the past 15 years, consistently outperforming the market. With an annualized return averaging 20.07%, Welltower has effectively generated a remarkable 7.9% more than broader market indices. As of now, Welltower boasts a...

Continue Reading
Cognizant and WRITER Team Up for AI-Driven Industry Change

Updated Category News Views 138

Cognizant Partners with WRITER for AI Innovations Cognizant (NASDAQ: CTSH), a major player in the technology and consulting sector, has recently announced an exciting partnership with WRITER. This collaboration aims to leverage artificial intelligence (AI) to accelerate transformation processes across different industries. Both companies are committed to driving...

Continue Reading
Biocodex Unveils Innovative Oral Suspension for Dravet Syndrome

Updated Category News Views 176

Revolutionizing Treatment for Dravet Syndrome In a significant development within the realm of pediatric epilepsy, Biocodex announces an exciting innovation involving DIACOMIT, otherwise known as stiripentol. This newly formulated oral suspension aims to refine treatment for young children suffering from Dravet syndrome, a particularly severe form of epilepsy that begins...

Continue Reading
Zinzino AB Reports Robust Growth in First Quarter Performance

Updated Category News Views 234

Zinzino AB Highlights Impressive Growth in Q1 2025 In an impressive testament to its operational strength, Zinzino AB has announced notable revenue growth for the first quarter of 2025. Rising to SEK 723.7 million from SEK 454.5 million indicates a significant growth rate of 59% compared to the same period last year. This remarkable surge reflects Zinzino's robust market...

Continue Reading
Roche's New CE Mark Enhances Antimicrobial Resistance Management

Updated Category News Views 118

Roche Enhances Diagnostic Capabilities with CE Mark Approval Roche has achieved a remarkable milestone by securing CE Mark approval for its mass spectrometry reagent pack dedicated to antibiotics drug monitoring. This significant development positions Roche’s automated mass spectrometry platform as the industry leader, boasting an extensive in-vitro diagnostic menu that...

Continue Reading